cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2001; 38:493-498
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Setoguchi, S.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Setoguchi, S.
Right arrow Articles by Takeshita, A.

CLINICAL STUDY: ENDOTHELIAL FUNCTION

Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease

Soko Setoguchi, MDa, Masahiro Mohri, MD, PhDa, Hiroaki Shimokawa, MD, PhDa and Akira Takeshita, MD, PhDa

a Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Manuscript received December 6, 2000; revised manuscript received March 29, 2001, accepted April 10, 2001.

Reprint requests and correspondence: Dr. Masahiro Mohri, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
mmohri{at}med.kyushu-u.ac.jp

OBJECTIVES

We aimed to determine whether intracoronary supplementation with nitric oxide (NO) synthase co-factor tetrahydrobiopterin (BH4) improves NO-dependent coronary microvascular dilation in patients with coronary risk factors but no significant organic stenosis.

BACKGROUND

Impaired coronary microvascular dilator reserve attributable to endothelial dysfunction plays an important role in the regulation of coronary blood flow (CBF).

METHODS

Fifteen patients were measured for CBF (Doppler-wire and quantitative coronary angiography). Stimulated release of NO in the coronary microcirculation was evaluated by percent increase in CBF (%{Delta}CBF) at graded doses of intracoronary acetylcholine (1, 3, 10 and 30 µg/min). Measurements were repeated after intracoronary co-infusion of BH4 (4 mg/min) and acetylcholine.

RESULTS

The patients were divided into two groups on the basis of CBF responses to acetylcholine: those with "diminished" (%{Delta}CBF <300%, n = 8) and "normal" (%{Delta}CBF >300%, n = 7) flow responses. Tetrahydrobiopterin significantly (p < 0.0001) improved acetylcholine-induced increases in CBF in patients with diminished flow responses, but exerted no effect in those with normal flow responses. Among the 15 studied patients, the magnitude of flow improvement by BH4 was inversely correlated with baseline flow responses (p < 0.02). Microvascular dilator response to direct NO donor (isosorbide dinitrate) was not affected by BH4.

CONCLUSIONS

We demonstrated for the first time that intracoronary BH4 improved acetylcholine-induced microvascular dilator responses in patients with endothelial dysfunction in vivo. Thus, supplementation with BH4 may be a novel therapeutic means to increase NO availability for patients with coronary microvascular disease.

Abbreviations and Acronyms
  BH4 = tetrahydrobiopterin
  CAD = coronary artery disease
  CBF = coronary blood flow
  LCA = left coronary artery
  NO = nitric oxide




This article has been cited by other articles:


Home page
HeartHome page
M Saito, H Okayama, K Nishimura, A Ogimoto, T Ohtsuka, K Inoue, G Hiasa, T Sumimoto, and J Higaki
Possible link between large artery stiffness and coronary flow velocity reserve
Heart, June 1, 2008; 94(6): e20 - e20.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
Y. Kondo, T. Ishikawa, K. Yamaguchi, T. Yada, and M. Fujisawa
Oral Administration of Tetrahydrobiopterin Attenuates Testicular Damage by Reducing Nitric Oxide Synthase Activity in a Cryptorchid Mouse Model
J Androl, March 1, 2008; 29(2): 153 - 163.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. I. Worthley, R. S. Kanani, Y.-H. Sun, Y. Sun, D. M. Goodhart, M. J. Curtis, and T. J. Anderson
Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries
Cardiovasc Res, December 1, 2007; 76(3): 539 - 546.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. L. Moens and D. A. Kass
Tetrahydrobiopterin and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2439 - 2444.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Cardounel, Y. Xia, and J. L. Zweier
Endogenous Methylarginines Modulate Superoxide as Well as Nitric Oxide Generation from Neuronal Nitric-oxide Synthase: DIFFERENCES IN THE EFFECTS OF MONOMETHYL- AND DIMETHYLARGININES IN THE PRESENCE AND ABSENCE OF TETRAHYDROBIOPTERIN
J. Biol. Chem., March 4, 2005; 280(9): 7540 - 7549.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Kawashima and M. Yokoyama
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 998 - 1005.
[Abstract] [Full Text] [PDF]



 
  cardiology careers collections past issues search home